Why the Latest Cancer Drugs May Not Be as Successful as They Seem

Kennedy: Multiple sclerosis, the great time thief, held at bay by 95-year-old
November 30, 2016
Felled by hepatitis C, a Vietnam vet joins comrades on the Wall
November 30, 2016
Show all

Why the Latest Cancer Drugs May Not Be as Successful as They Seem

Not all cancer drugs are living up to their hype.

There are more new drugs to treat cancer than ever before, but in some cases, they may not live up to their promise

But in an article published in the BMJ, scientists argue that some vaunted cancer medications aren’t living up to their promises to save more patients’ lives.

The reason has to do with the many ethically questionable practices throughout the drug-development process, says Peter Wise, retired from Charing Cross Hospital and Imperial College School of Medicine in London. These practices range from research by pharmaceutical companies to the way new compounds are tested, how data is interpreted, to the approval process by regulatory agencies and the way that doctors are incentivized to prescribe them. “There are different layers in the whole process and real problems all the way down the line,” he says.

Read Full Article: Why the Latest Cancer Drugs May Not Be as Successful as They Seem | TIME

Read Full Article: Why the Latest Cancer Drugs May Not Be as Successful as They Seem | TIME

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.